Latest Delaware Court of Chancery Stories
ANNAPOLIS, Md., Jan. 10, 2013 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced that the Delaware Supreme Court heard oral arguments today related to both parties' appeal in the Company's on-going litigation against SIGA Technologies. SIGA appealed the final judgment in favor of PharmAthene issued by the Delaware Court of Chancery on May 31, 2012, in which PharmAthene was awarded 50% of the net profits over a period of ten years from all sales of SIGA's smallpox antiviral...
ANNAPOLIS, Md., Aug. 7, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological( )and chemical threats, today reported its financial results for the second quarter ended June 30, 2012. "We continued to make progress toward meeting our financial and business objectives in the second quarter," commented Eric I. Richman, President and Chief Executive Officer. "During the quarter, work on our...
EAST BRUNSWICK, N.J., July 23, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Delaware Court of Chancery has issued a bench ruling granting both of Savient's motions in the lawsuit brought against the Company by Tang Capital Partners, LP and certain other holders of Savient's convertible notes. The Court of Chancery decided that the plaintiff noteholders do not have standing to bring an action to appoint a receiver for Savient and that...
NEW ORLEANS, June 15, 2012 /PRNewswire/ -- Louisiana Municipal Police Employees Retirement System (LMPERS), represented by court appointed co-lead counsel Kahn Swick & Foti, LLC, has reached a settlement of shareholder litigation on behalf of Barnes & Noble (NYSE: BKS) arising from the bookseller's 2009 acquisition of a textbook retailer wholly owned by Barnes & Noble's founder and controlling shareholder, Leonard S. Riggio. LMPERS and other shareholders had alleged...
BEIJING, June 8, 2012 /PRNewswire-Asia-FirstCall/ -- China Agritech, Inc., a Delaware corporation (the "Company"), today announced that the annual meeting of stockholders of the Company will be held on Monday, June 25, 2012 in Wilmington, Delaware. Stockholders of record as of the close of business on June 8, 2012 (U.S. Eastern Daylight Time) are entitled to receive notice of, and to vote at, the annual meeting and any adjournment or postponement of that meeting. The annual...
ANNAPOLIS, Md., June 1, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) today announced that the Delaware Court of Chancery has issued its final judgment in the Company's litigation against SIGA Technologies. Upholding its September 22, 2011 ruling, the Court awarded PharmAthene 50% of the net profits over a period of ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits....
BIRMINGHAM, Ala., May 14, 2012 /PRNewswire/ -- Vulcan Materials Company (NYSE:VMC) announced that the Delaware Court of Chancery today issued its order and judgment implementing its earlier ruling enjoining Martin Marietta Materials (NYSE: MLM) and also denied Martin Marietta's motion for a stay pending appeal. Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Vulcan. Goldman, Sachs & Co. and BofA Merrill Lynch are acting as financial advisors to Vulcan....
ANNAPOLIS, Md., May 8, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological( )and chemical threats, today reported its financial results for the first quarter ended March 31, 2012. Eric I. Richman, President and Chief Executive Officer, commented, "We are off to a great start in 2012 in regards to accomplishing our strategic objectives and meeting our financial goals. We are excited to...
ANNAPOLIS, Md., March 8, 2012 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the year ended December 31, 2011. "We were gratified by the favorable ruling from the Delaware Court of Chancery in September of 2011," remarked Eric I. Richman, President and Chief Executive Officer. "Under that ruling, the Court awarded PharmAthene the...
ANNAPOLIS, Md., Dec. 19, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) today announced that the Delaware Court of Chancery has denied SIGA Technologies' motion for reargument filed on October 4, 2011, upholding the Court's original September 22, 2011 decision awarding PharmAthene 50% of the net profits over ten years from all sales of SIGA's smallpox antiviral therapeutic, ST-246, and related products, after SIGA receives the first $40 million in net profits. In addition,...
